Maze Therapeutics

Maze Therapeutics is a clinical-stage precision medicine company developing small-molecule and other treatments for common diseases with significant unmet medical need, with a focus on kidney disease. Its Compass platform pairs human genetics with variant functionalization to connect specific genetic drivers to disease biology and design targeted medicines, including programs for APOL1-mediated kidney disease and SLC6A19-related conditions. Surfaced as a portfolio company of a16z and gv, it was added to the API Evangelist network as a lead; enrichment confirmed it publishes no public developer API, documentation, or discovery surface.

Maze Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Precision Medicine, Biotechnology, Genetics, and Kidney Disease.

🌐 Visit website 📡 Source on GitHub

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyPrecision MedicineBiotechnologyGeneticsKidney DiseaseDrug DiscoveryHealthcare

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 7.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/maze-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: maze-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/maze-therapeutics.png
name: Maze Therapeutics
description: Maze Therapeutics is a clinical-stage precision medicine company developing small-molecule and other treatments
  for common diseases with significant unmet medical need, with a focus on kidney disease. Its Compass platform pairs human
  genetics with variant functionalization to connect specific genetic drivers to disease biology and design targeted medicines,
  including programs for APOL1-mediated kidney disease and SLC6A19-related conditions. Surfaced as a portfolio company of
  a16z and gv, it was added to the API Evangelist network as a lead; enrichment confirmed it publishes no public developer
  API, documentation, or discovery surface.
url: https://raw.githubusercontent.com/api-evangelist/maze-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Precision Medicine
- Biotechnology
- Genetics
- Kidney Disease
- Drug Discovery
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/maze-therapeutics-domain-security.yml
- type: Website
  url: https://mazetx.com
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1

Maze Therapeutics

Kin Score

Security Posture 1

Maze Therapeutics Domain Security

Resources

Access & Security 1

Company 1

Source (apis.yml)